The Russian pharmaceutical market , one of the fastest developing markets, is positioned at the forefront of pharmerging markets and is projected to reach a value of US $31.2 billion by 2019, growing at a double-digit rate and twice the worldwide average.
Russia is benefiting from a growing economy and with the increased healthcare investments being made by the government, the market is set to enjoy a sustained and prolonged period of expansion.
The Russian pharmaceutical market is experiencing a grand period of expansion. With increased support from the government, coupled with the desire to increase domestic production by 50 per cent, the Russian pharma landscape is proving to be a very attractive venture for international buyers and suppliers looking to break into this market. . Russia is currently the eleventh largest pharmaceutical market in the world.
The growth in Russia’s pharma market can largely be attributed to its population of 144 million, and with increased disposable incomes, and an increasing health conscious demand is rapidly expanding. An overwhelming 76 per cent of total pharmaceutical sales are attributed to imported drugs, highlighting the strong presence of international companies within Russia, with many more now looking to capitalise on this attractive market.
The Russian Government's ambitious Pharma 2020 plan, introduced in 2009, includes funding of nearly US$5 billion and seeks to dramatically increase domestic pharmaceutical manufacturing and R&D capabilities.
As a result of the Pharma 2020 plan the demand for international pharmaceutical ingredients and manufacturing and packaging equipment will be increasing dramatically in order to upgrade existing manufacturing sites to GMP standards.
Specific Pharma 2020 goals include increasing domestic finished-dosage manufacturing capacity, direct investment by the Russian government and funding of $ five billion.
CPhI Russia @ IPhEB is Russia’s most comprehensive pharma event co-located with the IPhEB conference being held from April 27-29 , 2015 at VVC, Russia opens the gateway to the Russian, CIS and CEE markets.CPhI Russia and IPhEB is Russia’s most comprehensive pharma event, providing a crucial networking point for domestic and global business opportunities.
In 2014, over 3000 attendees were recorded from 56 different countries, and 200+ companies from over 30 countries exhibited. Similar numbers are expected at the 2015 event in Moscow.
This year’s event opens with the Russia’s Pharma 2020 plan as its backdrop and with an active Government looking to help boost the domestic pharma manufacturing base.
Hosting a range of exhibitors in the field of pharma ingredients, finished dosage, machinery, equipment, technology and outsourcing, this event offers unique opportunity to initiate business and build partnerships in the booming Russian and CIS pharma markets. With a strong focus on content, CPhI Russia will offer many unique networking opportunities.
CPhI will be co-located with ICSE, P-MEC, and Innopack, as well as new addition Food ingredients (Fi) and Health ingredients Russia (Hi). The event is being organised by UBM EMEA
CPhI is partnering with IPhEB, a highly respected Russian pharma event. The CPhI Russia @ IPhEB Forum is specifically designed to provide invaluable insights into the fast-growing Russian pharmaceutical market
Key reasons to exhibit at CPhI Russia 2015 include creating partnerships with leading Russian companies and government institutions, networking with top-level executives and gain in-depth market knowledge during the International Forum, a dedicated matchmaking program with other networking opportunities
This year sees the return of the highly successful matchmaking programme. This feature allows both visitors and exhibitors to identify specific companies that match their business needs and leads to more efficient networking across the three-day event. Also returning in 2015 are the Exhibitor Showcases – spanning the entire event, they cover trending industry topics – and a bespoke mobile app with a floor plan, forum schedule and exhibitor list that is designed to ease on-site navigation.
A two-day conference forum will run alongside the exhibition from April 27 to 28. Key industry topics will be discussed in several conferences and speeches. Examples include:
*Implementation principles of good distribution practice and good storage practice of pharmaceutical products within the Eurasian Economic Union
*Harmonization of education training programmes for the pharmaceutical industry
*Harmonization of standards and requirements for laboratory research within the Eurasian Economic Union
A highly successful matching making programme for both visitors and exhibitors provides direct access to individual companies matching your specific business needs. Exhibitor Showcases, across the full three days, covering trending topics spanning the entire Pharma industry. A bespoke mobile app, designed to ease on-site navigation with a complete floor plan, forum schedule and exhibitor list.
There will be 16 exhibitors from India, including leading Indian companies such as Nosch Labs Pvt Limited and Ultratech India Ltd.
In 2014, over 3000 attendees were recorded from 56 different countries, and over 200 companies from over 30 countries exhibited. Similar numbers are expected at the 2015 event in Moscow.
The two-day conference platform, running on April 27 and April 28 will provide seminars and speeches on key industry topics that offer in-depth insights into industry trends and explore the potential of new drug targets and products.
The first day of the conference i.e. April 27 will have plenary session on Harmonization of pharmaceutical products circulation within the Eurasian Economic Union.
After the session there will be official event opening ceremony. The second topic for the conference will be Harmonization of standards and requirements for pharmaceutical products within the Eurasian Economic Union. Moderator for the event will be Igor Narkevich, Vice-Chancellor of St. Petersburg State Chemical-Pharmaceutical Academy, Ministry of Health of the Russian Federation.
Several hundred exhibitors are expected to attend the event including leading players from Russia’s growing pharmaceutical market such as Protek-SVM and NC Pharm. Furthermore, a great number of international companies will also be exhibiting, exemplifying the globalisation of the Russian pharma industry – with delegates and industry leaders from many markets including Japan, Italy, India and China are expected to attend. On-site Exhibitor Showcases reflect this increased global presence and offer in-depth insights into industry trends from a domestic and international stand-point.
CPhI Russia @ IPhEB continues to expand year-on-year, keeping pace with the industry’s growth and providing a large, varied portfolio for attendees – 2015 marks a move to the nation’s capital and expansion to a full 3-day event. There has been significant increase in the number of visitors and exhibitors at CPhI Russia @ IPhEB, emphasising the importance of this central meeting where pharma executives can connect and develop their business opportunities.
Last year’s event was extremely successful and prompted organizers to increase CPhI Russia @ IPhEB to a full three-day event and move to the nation’s capital for 2015. Over 3000 senior professionals and industry representatives gathered at CPhI Russia @ IPhEB and this is expected to be repeated this year also.